Demelon Capsule 3 mg contains Rivastigmine Tartrate 3 mg, a cholinesterase inhibitor used in the management of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. Rivastigmine enhances brain function by increasing the availability of acetylcholine, a neurotransmitter essential for memory, learning, and cognition, which is typically deficient in dementia patients.
Dementia is a progressive neurological condition characterized by memory loss, confusion, difficulty in thinking, and impaired daily activities. Demelon Capsule 3 mg helps improve cognitive performance, attention, and daily living skills, slowing the functional decline associated with dementia. This makes it an important therapy for patients in the early stages of the disease, helping maintain independence and improving overall quality of life.
The 3 mg dose serves as a starting or titration dose, allowing physicians to gradually adjust therapy based on tolerance and response. It is available in an oral capsule form for convenient and accurate administration.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Demelon Capsule 3 mg is indicated for:
Treatment of mild to moderate Alzheimer’s disease
Management of Parkinson’s disease dementia
Improvement of cognitive function, memory, and attention in dementia patients
Support of daily living activities and behavioral functions in affected individuals
Enhances cholinergic activity in the brain, improving memory and cognition
Slows progression of symptoms in early to moderate dementia
Improves attention, reasoning, and day-to-day functioning
Supports patient independence and quality of life
Oral capsule allows flexible dosing and easy administration
Rivastigmine Tartrate, the active ingredient in Demelon, works as a reversible inhibitor of acetylcholinesterase and butyrylcholinesterase, the enzymes responsible for breaking down acetylcholine in the brain. By inhibiting these enzymes, rivastigmine increases acetylcholine levels, enhancing communication between nerve cells. This improvement in cholinergic signaling helps restore cognitive function, memory retention, and learning abilities in patients with dementia.
The recommended starting dose is usually 3 mg twice daily, taken orally.
Capsules should be swallowed with water and preferably with meals to minimize gastrointestinal side effects.
Gradual dose titration may be advised based on tolerance, typically increasing to 6 mg or higher as prescribed.
Consistent daily intake is important for maintaining therapeutic effects and achieving optimal cognitive improvement.
Use cautiously in patients with heart disease, gastrointestinal ulcers, liver or kidney impairment, or seizure disorders.
Monitor for gastrointestinal symptoms, weight changes, or slow heart rate (bradycardia).
Avoid abrupt discontinuation; always consult a healthcare provider before stopping or adjusting the dose.
Inform your physician of all concomitant medications to avoid potential drug interactions.
Not recommended for severe dementia or in patients with known hypersensitivity to rivastigmine.
Demelon Capsule 3 mg is generally well tolerated. Side effects may include:
Nausea or vomiting
Loss of appetite
Diarrhea
Dizziness or headache
Rarely, bradycardia or fainting
Most side effects are mild and often decrease with continued therapy or gradual dose escalation.
Store below 30°C in a dry, cool place, protected from light and moisture. Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet